You just read:

RXi Pharmaceuticals Advances Immuno-Oncology Pipeline by Selecting Two sd-rxRNA Compounds for Preclinical Development and Sourcing cGMP Manufacturing

News provided by

RXi Pharmaceuticals Corporation

Aug 08, 2017, 07:05 ET